Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enovachem Pharmaceuticals, a division of Asclemed USA, Inc., is a pharmaceutical manufacturing and contract packaging company based in Torrance, California. The company specializes in the development and assembly of patented convenience kits, including Single Use Injection Kits (SUIK™) and Single Source Active Pharmaceutical Ingredient (SSAPI™) kits, designed to enhance safety and compliance for healthcare providers. Their extensive product portfolio also includes bioidentical hormone wellness products, over-the-counter (OTC) medications, and custom-blended supplements. As an FDA-registered and DEA-licensed manufacturer, Enovachem provides cGMP-compliant solutions that streamline clinical workflows for private practices, pharmacies, and hospitals. The company is recognized for its ability to rapidly adapt to the changing pharmaceutical landscape while maintaining a focus on high-quality patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enovachem.